Vertex Pharmaceuticals (US92532F1003)

MK:Large Cap
Z-Score:12.81
F-Score:6
Symbol:VRTX
Index:
Sector:Healthcare
Industry:Biotechnology & Drugs
Chart: onvista.de

Levermann-Analysis Sell

CriterionValuePoint
1. Return on Equity CY31.22 %1
2. EBIT-Margin CY46.41 %1
3. Equity Ratio CY73.92 %1
4. P/E ratio 5Y23.06-1
5. P/E ratio CY19.44-1
6. Analyst opinions1.15-1
7. Reaction to quarterly figures3.77 %1
8. Profit revision 2021 : -1.61 %
2022 : -2.21 %
0
9. Price today vs. Price 6 months ago-0.83 %0
10. Price today vs. Price 1 year ago-25.01 %-1
11. Price momentumFactor 9: 0
Factor 10: -1
0
12. Three-month-reversalFeb: Performance < NASDAQ 100-Perf.
Mar: Performance < NASDAQ 100-Perf.
Apr: Performance < NASDAQ 100-Perf.
1
13. Profit growth13.02 %1
2
Sorry Altman analysis not avilable for this stock

Point history



Dieser Inhalt ist nur für Premium-Mitglieder abrufbar.


Login Registration